It is not necessary to determine specificity and accuracy of the imaging modalities. The imaging here is only meant to assist in determining the metabolic and anatomic tumour areas in the prostate. Missing a tumour part is not a problem yet because the whole prostate is being treated to the minimal required dose. Overdosage on prostate tissue is not a clinical problem.